Texas Yale Capital Corp. Increases Stake in UnitedHealth Group Incorporated $UNH

Texas Yale Capital Corp. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 161.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,587 shares of the healthcare conglomerate’s stock after purchasing an additional 4,070 shares during the period. Texas Yale Capital Corp.’s holdings in UnitedHealth Group were worth $2,055,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. HHM Wealth Advisors LLC increased its stake in UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after purchasing an additional 26 shares during the period. Brogan Financial Inc. increased its stake in shares of UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after buying an additional 27 shares during the period. West Wealth Group LLC boosted its position in UnitedHealth Group by 3.2% during the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after buying an additional 27 shares during the period. Hemington Wealth Management raised its stake in shares of UnitedHealth Group by 2.5% during the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after acquiring an additional 28 shares during the last quarter. Finally, Tlwm boosted its holdings in shares of UnitedHealth Group by 1.0% during the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after purchasing an additional 28 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $324.29 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The firm has a market capitalization of $293.75 billion, a price-to-earnings ratio of 16.93, a PEG ratio of 2.28 and a beta of 0.47. The firm has a 50 day moving average price of $345.84 and a 200-day moving average price of $323.37. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the previous year, the business earned $7.15 earnings per share. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Mizuho increased their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Barclays raised their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Finally, UBS Group upped their target price on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.